NASDAQ:SLS

Sellas Life Sciences Group Stock Predictions

etoro logo Buy SLS
*Your capital is at risk
$8.23
-0.81 (-8.96%)
At Close: Jun 05, 2026
Currently predicting for Mon, 8 Jun 2026

SLS Prediction Chart

SLS Predictions History

Latest community submissions for SLS.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 1, 2026 $9.61 +3.18% $9.07 X 94.09% 0
Jun 1, 2026 $9.01 -3.18% $9.07 V 99.38% 4
Jun 1, 2026 $9.12 -1.99% $9.07 V 99.39% 4
Jun 1, 2026 Bullish $9.07 X 0
May 1, 2026 $5.06 +2.15% $4.93 X 97.44% 0
May 1, 2026 $4.81 -2.86% $4.93 V 97.53% 1
May 1, 2026 $4.86 -1.79% $4.93 V 98.61% 2
May 1, 2026 Bullish $4.93 V 0
Apr 16, 2026 $4.75 -3.19% $4.93 X 96.42% 0
Apr 16, 2026 $4.81 -1.99% $4.93 X 97.61% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SLS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SELLAS LIFE SCIENCES GROUP INC.
SELLAS Life Sciences Group
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE